Free shipping on all orders over $ 500

MC1568

Cat. No. M2014

All AbMole products are for research use only, cannot be used for human consumption.

MC1568 Structure
Size Price Availability Quantity
5mg USD 40  USD40 In stock
10mg USD 60  USD60 In stock
50mg USD 180  USD180 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MC1568 is a selective inhibitor of class IIa histone deacetylases (HDACs). In vivo, MC1568 shows an apparent tissue-selective HDAC inhibition. In skeletal muscle and heart, MC1568 inhibits the activity of HDAC4 and HDAC5 without affecting HDAC3 activity, thereby leaving MEF2-HDAC complexes in a repressed state. In F9 cells, MC1568 specifically blocks endodermal differentiation despite not affecting retinoic acid-induced maturation of promyelocytic NB4 cells. In 3T3-L1 cells, MC1568 attenuates PPARγ-induced adipogenesis. Finally, treatment of pancreatic explants with the selective class IIa HDAC inhibitor MC1568 enhances expression of Pax4, a key factor required for proper β-and δ-cell differentiation and amplifies endocrine β- and δ-cells.

Product Citations
Customer Product Validations & Biological Datas
Source Toxicol Sci (2016). Figure 1. MC1568
Method Cell Viability
Cell Lines SH-SY5Y cells
Concentrations 5 μM
Incubation Time 24h
Results Interestingly, cell viability was significantly ameliorated when cells were pretreated with MC1568, but not with MS275 compared with cells exposed to thimerosal alone
Chemical Information
Molecular Weight 314.31
Formula C17H15FN2O3
CAS Number 852475-26-4
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lenoir O, et al. Diabetes. Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.

[2] Nebbioso A, et al. J Mol Endocrinol. HDACs class II-selective inhibition alters nuclear receptor-dependent differentiation.

[3] Nebbioso A, et al. EMBO Rep. Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes.

[4] Duong V, et al. Mol Cancer Res. Specific activity of class II histone deacetylases in human breast cancer cells.

Related HDAC Products
SIS17

SIS17 is a histone deacetylase 11 (HDAC 11) inhibitor with an IC50 value of 0.83 μM.

Belinostat

Belinostat (PXD101) is a novel HDAC inhibitor with an IC50 of 27 nM.

CUDC-101

CUDC-101 is a potent multitargeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.

Givinostat hydrochloride monohydrate

ITF2357 (Givinostat, Gavinostat) is a histone deacetylase inhibitor. The IC50 values for maize HDAC preparations HD2, HD-1B and HD-1A are 10, 7.5 and 16 nM respectively.

Niltubacin

Niltubacin, as an inactive derivative of Tubacin, is a highly potent and selective, reversible cell-permeable inhibitor of HDAC6.

  Catalog
Abmole Inhibitor Catalog




Keywords: MC1568 supplier, HDAC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.